We are pleased to announce the proposed issue by KIBB of up to 35,000,000 European style non-collateralised cash-settled call warrants over the ordinary shares of PHARMA.

The PHARMA-CE is constituted by the Deed Poll dated 13 May 2020 executed by us, as supplemented from time to time. The PHARMA-CE is subject to terms and conditions of the Base Prospectus dated 18 May 2020, the First Supplementary Base Prospectus dated 9 October 2020 and the Term Sheet dated 2 December 2020.

The PHARMA-CE will be listed on the Structured Warrants Board of Malaysia Securities Berhad and issued by KIBB under the Base Prospectus dated 18 May 2020 and the First Supplementary Base Prospectus dated 9 October 2020.

A summary of principal terms of the PHARMA-CE is set out in Table 1.

This announcement is dated 2 December 2020.